Management of Children With or Exposed to HIV

  • Authors: James A. McAuley, MD, MPH; Mariam Aziz, MD (More Info)
  • Associate Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/12/18 (What's New)

Summary

  • Current DHHS guidelines recommend that 4-week neonatal zidovudine can be used in infants of mothers who received standard combination ART during pregnancy with continuous virologic suppression and no maternal adherence concerns[DHHS Perinatal]
    • Frequency of hematologic monitoring should be based on specific circumstances of each case[DHHS Perinatal]
    • If anemia or other hematologic abnormalities occur, the decision to stop or continue prophylaxis should be individualized, and consultation with a pediatric HIV infection expert is recommended[DHHS Perinatal]

Action required

Keywords: Biomedical Prevention, Hematologic Complications, Pediatric/Adolescent Patients, Pediatric/Adolescent Patients

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.